Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
03/05/20211:31PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/04/20215:46PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/04/20215:43PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/04/20214:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/25/20216:04PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/24/20214:38PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/24/20216:08AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/23/20216:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/16/20214:05PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/16/202111:07AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/16/20219:51AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/16/20216:44AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/16/20216:40AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/12/20214:51PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/12/20214:42PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/15/20216:24AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/14/20215:13PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/13/20216:03AMEdgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/07/20216:01PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/07/20216:01AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/22/20206:29AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/22/20206:27AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/07/20206:20AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/30/20208:01AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/16/20204:36PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/16/20204:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/16/20204:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/09/20207:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/12/20207:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ...NASDAQ:SNSSSunesis Pharmaceuticals Inc
09/18/20204:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS